285 related articles for article (PubMed ID: 25443789)
21. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.
Wang B; Lv L; Wang Z; Zhao Y; Wu L; Fang X; Xu Q; Xin H
Biomaterials; 2014 Jul; 35(22):5897-907. PubMed ID: 24743033
[TBL] [Abstract][Full Text] [Related]
23. Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles.
Zhang B; Shen S; Liao Z; Shi W; Wang Y; Zhao J; Hu Y; Yang J; Chen J; Mei H; Hu Y; Pang Z; Jiang X
Biomaterials; 2014 Apr; 35(13):4088-98. PubMed ID: 24513320
[TBL] [Abstract][Full Text] [Related]
24. Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy.
Feng X; Gao X; Kang T; Jiang D; Yao J; Jing Y; Song Q; Jiang X; Liang J; Chen J
Bioconjug Chem; 2015 Aug; 26(8):1850-61. PubMed ID: 26222392
[TBL] [Abstract][Full Text] [Related]
25. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J
Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619
[TBL] [Abstract][Full Text] [Related]
26. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.
Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y
J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518
[TBL] [Abstract][Full Text] [Related]
27. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
28. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.
Gao H; Qian J; Cao S; Yang Z; Pang Z; Pan S; Fan L; Xi Z; Jiang X; Zhang Q
Biomaterials; 2012 Jul; 33(20):5115-23. PubMed ID: 22484043
[TBL] [Abstract][Full Text] [Related]
29. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract][Full Text] [Related]
30. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
[TBL] [Abstract][Full Text] [Related]
31. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
[TBL] [Abstract][Full Text] [Related]
32. Glioma-Targeted Drug Delivery Enabled by a Multifunctional Peptide.
Zhang M; Chen X; Ying M; Gao J; Zhan C; Lu W
Bioconjug Chem; 2017 Mar; 28(3):775-781. PubMed ID: 27966896
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Jiang X; Xin H; Ren Q; Gu J; Zhu L; Du F; Feng C; Xie Y; Sha X; Fang X
Biomaterials; 2014 Jan; 35(1):518-29. PubMed ID: 24125772
[TBL] [Abstract][Full Text] [Related]
35. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
Li Y; Zheng X; Gong M; Zhang J
Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
[TBL] [Abstract][Full Text] [Related]
36. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Cui Y; Xu Q; Chow PK; Wang D; Wang CH
Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
[TBL] [Abstract][Full Text] [Related]
37. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
38. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
[TBL] [Abstract][Full Text] [Related]
39. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Mbimba T; Bui T; Harrison K; Sutariya V
J Drug Target; 2011 Nov; 19(9):837-45. PubMed ID: 21692650
[TBL] [Abstract][Full Text] [Related]
40. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
